Inventor · disambiguated record
Samuel C. Wagner
Also filed as: WAGNER SAMUEL · WAGNER SAMUEL C
5 granted patents·42 pending applications·21 citations·filing 2009–2024
78Inventor score
Files withBATU BIOLOGICS INC33MYELOID THERAPEUTICS INC9BATU BIOLOG INC2BATU BIOLOGICS1DE GIER JAN WILLEM1
Top patents by PatentIndex Score
47 records- 0196US11918605B1Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Granted Mar 5, 2024·6 cites·30 claims
- 0296US11517589B2Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Granted Dec 6, 2022·9 cites·23 claims
- 0395US11918604B2Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Granted Mar 5, 2024·3 cites·25 claims
- 0487US2024207309A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0580US2022175831A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0680US2022175830A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0780US2022202856A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0879US2022118010A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0976US2021252053A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1066US8138324B2Expression system for proteinsDE GIER JAN WILLEM·Filed 2009·Granted Mar 20, 2012·3 cites·20 claims
- 1163US2017151281A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 1257US2019167720A1Gene editing for immunological destruction of neoplasiaBATU BIOLOGICS INC·Filed 2018·Application pending·0 cites
- 1351US2016228547A1Chimeric antigen receptor targeting of tumor endotheliumBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 1450US2020297829A1Integrative Immunotherapy for Cancer TreatmentBATU BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 1550US2018008670A1Chimeric antigen receptor targeting of tumor endotheliumBATU BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 1649US2017020922A1Gene editing for immunological destruction of neoplasiaBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 1749US2019224292A1Methods of Augmenting Tumor Vaccine Efficacy through Endothelial TargetingBATU BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 1849US2019201511A1Placental Based Contraceptive VaccineBATU BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 1949US2019255127A1Augmentation of Oncolytic Viral Efficacy through Immunological Targeting Tumor Endothelial CellsBATU BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 2046US2019161798A1Selection of Donors for Generation of Anti-Angiogenic Vaccine Compositions Including ValloVaxBATU BIOLOGICS INC·Filed 2018·Application pending·0 cites
- 2146US2018264096A1Prophylactic Vaccine to Tumor AngiogenesisBATU BIOLOGICS INC·Filed 2018·Application pending·0 cites
- 2244US2018280444A1Nanoparticle based tumor endothelial targeting vaccineBATU BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 2344US2019239937A1Augmentation of Abscopal Effect of Cryotherapy and other Tumor Cell Death by Anti-angiogenic and Anti-tumor VaccinationBATU BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 2444US2017348388A1Adjuvants useful for stimulation of immunity to tumor endothelial cellsBATU BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 2544US2017348361A1Probiotic augmentation of anti-tumor endothelium immune responsesBATU BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 2643US2019117703A1Immunological treatment of liver failureBATU BIOLOGICS INC·Filed 2018·Application pending·0 cites
- 2743US2017216354A1Clinically useful non-antigen pulsed dendritic cellsBATU BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 2843US2018110847A1Immunotherapy of Cancer by Induction of Immunologically-Mediated Selective Killing of Tumor Vasculature Using Modified Endothelial Cells and Progenitors ThereofBATU BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 2943US2019282641A1Generation of Tumor Endothelium Specific VirusesBATU BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 3042US2017100468A1Amplification of epitope specific personalized anti-angiogenic immune responsesBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3141US2018264049A1Immunotherapy of Aberrant Ocular Angiogenesis by Placental VaccinationBATU BIOLOGICS INC·Filed 2018·Application pending·0 cites
- 3241US2017165332A1Gene edited antigen presenting cellsBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3340US2017196951A1Polyvalent anti-tumor fibroblast vaccineBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3440US2017128555A9Placental compositions for stimulation of immunity to pd-l1BATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3540US2017152506A1Inactivation of lymphocyte immunological checkpoints by gene editingBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3640US2017107510A1Dna nanoparticle based checkpoint inhibitorsBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3739US2017100438A1Treatment of glioma by anti-angiogenic active immunization for direct tumor inhibition and augmentation of chemotherapy, immunotherapy and radiotherapy efficacyBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3839US2016237407A1Universal donor chimeric antigen receptor cellsBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3939US2016206717A1Stimulation of immunity to endothelial cells, endothelial-like cells, and intratumor vascular channels derived from tumor tissueBATU BIOLOG INC·Filed 2016·Application pending·0 cites
- 4039US2016213764A1Composite tissue cancer vaccineBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 4138US2017021002A1Augmentation of cancer and cancer endothelial vaccine immunogenicity by histone deacetylase inhibitorsBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 4237US2016074437A1Immunological treatment of liver failureBATU BIOLOG INC·Filed 2015·Application pending·0 cites
- 4337US2017095545A1Inhibition of tumor angiogenesis by checkpoint inhibitors and active vaccinationBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 4437US2016231323A1Protection of tcr signaling chains in cancer patients and enhancement of car-t cell therapyBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 4535US2016340650A1Blood derived immune stimulatory compositionsBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 4632US9687472B2Use of antioxidants as an adjuvant to immune stimulators to augment tumor immunity and prevent toxicity associated with oxidative stressBATU BIOLOGICS·Filed 2015·Granted Jun 27, 2017·0 cites·9 claims
- 4728US2016022761A1Derepression of immunity in oncological and virological conditions by high mobility group box 1 derived peptidesWAGNER SAMUEL C·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Samuel C. Wagner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →